

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.34490691 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.34490691 |
| 3 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87526853 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 4.47518959 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.47518959 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.40552125 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.40552125 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.40552125 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.40552125 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.40552125 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.40552125 |
| 12 | detection of bacterium (GO:0016045) | 4.37004416 |
| 13 | detection of other organism (GO:0098543) | 4.30984367 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 4.24379133 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.24379133 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.19685792 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.05770638 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 4.04559777 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.04302581 |
| 20 | positive thymic T cell selection (GO:0045059) | 3.94323236 |
| 21 | response to peptidoglycan (GO:0032494) | 3.94020217 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 3.91848649 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91832142 |
| 24 | fatty acid beta-oxidation (GO:0006635) | 3.88474744 |
| 25 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.86353147 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.86312622 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 3.84384448 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.83671754 |
| 29 | negative thymic T cell selection (GO:0045060) | 3.80915105 |
| 30 | valine metabolic process (GO:0006573) | 3.80392938 |
| 31 | aromatic amino acid family catabolic process (GO:0009074) | 3.80242016 |
| 32 | cellular extravasation (GO:0045123) | 3.79384520 |
| 33 | negative regulation of interleukin-12 production (GO:0032695) | 3.74925484 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.70909061 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.70909061 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.69758957 |
| 37 | negative T cell selection (GO:0043383) | 3.67017483 |
| 38 | lysine catabolic process (GO:0006554) | 3.64119407 |
| 39 | lysine metabolic process (GO:0006553) | 3.64119407 |
| 40 | leukocyte aggregation (GO:0070486) | 3.63422205 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61545532 |
| 42 | defense response to protozoan (GO:0042832) | 3.57358299 |
| 43 | glyoxylate metabolic process (GO:0046487) | 3.55319203 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.54135725 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 3.52433632 |
| 46 | fatty acid oxidation (GO:0019395) | 3.52233500 |
| 47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.52033809 |
| 48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.51777647 |
| 49 | fatty acid catabolic process (GO:0009062) | 3.51002414 |
| 50 | tryptophan catabolic process (GO:0006569) | 3.49564699 |
| 51 | indole-containing compound catabolic process (GO:0042436) | 3.49564699 |
| 52 | indolalkylamine catabolic process (GO:0046218) | 3.49564699 |
| 53 | phospholipid efflux (GO:0033700) | 3.47202696 |
| 54 | lipid oxidation (GO:0034440) | 3.46466889 |
| 55 | B cell receptor signaling pathway (GO:0050853) | 3.44973176 |
| 56 | response to type I interferon (GO:0034340) | 3.44397139 |
| 57 | detection of external biotic stimulus (GO:0098581) | 3.42991004 |
| 58 | type I interferon signaling pathway (GO:0060337) | 3.40520049 |
| 59 | cellular response to type I interferon (GO:0071357) | 3.40520049 |
| 60 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.40048839 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.38954018 |
| 62 | kynurenine metabolic process (GO:0070189) | 3.38690485 |
| 63 | thymic T cell selection (GO:0045061) | 3.38347745 |
| 64 | 2-oxoglutarate metabolic process (GO:0006103) | 3.38145274 |
| 65 | tryptophan metabolic process (GO:0006568) | 3.36235509 |
| 66 | T cell selection (GO:0045058) | 3.35170884 |
| 67 | amino-acid betaine metabolic process (GO:0006577) | 3.34930343 |
| 68 | germinal center formation (GO:0002467) | 3.33784945 |
| 69 | response to protozoan (GO:0001562) | 3.32887824 |
| 70 | high-density lipoprotein particle remodeling (GO:0034375) | 3.31806413 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 3.28505566 |
| 72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27372187 |
| 73 | regulation of gamma-delta T cell activation (GO:0046643) | 3.25349659 |
| 74 | T cell migration (GO:0072678) | 3.25002221 |
| 75 | response to interleukin-15 (GO:0070672) | 3.24059048 |
| 76 | mannose metabolic process (GO:0006013) | 3.23558417 |
| 77 | carnitine shuttle (GO:0006853) | 3.23523147 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.23265497 |
| 79 | urea cycle (GO:0000050) | 3.21960709 |
| 80 | urea metabolic process (GO:0019627) | 3.21960709 |
| 81 | myeloid cell activation involved in immune response (GO:0002275) | 3.21394868 |
| 82 | positive T cell selection (GO:0043368) | 3.20582878 |
| 83 | fatty acid transmembrane transport (GO:1902001) | 3.20079029 |
| 84 | regulation of T cell tolerance induction (GO:0002664) | 3.19692134 |
| 85 | bile acid biosynthetic process (GO:0006699) | 3.18086387 |
| 86 | carnitine metabolic process (GO:0009437) | 3.18048386 |
| 87 | acylglycerol homeostasis (GO:0055090) | 3.17865765 |
| 88 | triglyceride homeostasis (GO:0070328) | 3.17865765 |
| 89 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.17190280 |
| 90 | tricarboxylic acid metabolic process (GO:0072350) | 3.16968113 |
| 91 | negative regulation of T cell mediated immunity (GO:0002710) | 3.15578424 |
| 92 | detection of biotic stimulus (GO:0009595) | 3.13945209 |
| 93 | regulation of cholesterol homeostasis (GO:2000188) | 3.12742048 |
| 94 | monocarboxylic acid catabolic process (GO:0072329) | 3.12712322 |
| 95 | negative regulation of innate immune response (GO:0045824) | 3.11714806 |
| 96 | regulation of B cell differentiation (GO:0045577) | 3.10209187 |
| 97 | regulation of cholesterol esterification (GO:0010872) | 3.08272160 |
| 98 | intestinal cholesterol absorption (GO:0030299) | 3.07301842 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05873101 |
| 100 | reverse cholesterol transport (GO:0043691) | 3.05759657 |
| 101 | regulation of mast cell degranulation (GO:0043304) | 3.04815477 |
| 102 | regulation of tolerance induction (GO:0002643) | 3.04709666 |
| 103 | B cell mediated immunity (GO:0019724) | 3.04108590 |
| 104 | plasma lipoprotein particle assembly (GO:0034377) | 3.03673197 |
| 105 | response to host immune response (GO:0052572) | 3.03671872 |
| 106 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.03671872 |
| 107 | sulfur amino acid catabolic process (GO:0000098) | 3.02797365 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.02756073 |
| 109 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.02756073 |
| 110 | respiratory burst (GO:0045730) | 3.00315029 |
| 111 | phospholipid homeostasis (GO:0055091) | 2.99061184 |
| 112 | neutrophil activation (GO:0042119) | 2.97558978 |
| 113 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96387303 |
| 114 | tolerance induction (GO:0002507) | 2.94741565 |
| 115 | nitrogen cycle metabolic process (GO:0071941) | 2.94258643 |
| 116 | regulation of sequestering of triglyceride (GO:0010889) | 2.94080100 |
| 117 | short-chain fatty acid metabolic process (GO:0046459) | 2.93899672 |
| 118 | protein carboxylation (GO:0018214) | 2.93509310 |
| 119 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.93509310 |
| 120 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.91492208 |
| 121 | cellular response to interleukin-15 (GO:0071350) | 2.91133100 |
| 122 | microglial cell activation (GO:0001774) | 2.91103199 |
| 123 | ethanol oxidation (GO:0006069) | 2.90946315 |
| 124 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88938681 |
| 125 | granulocyte activation (GO:0036230) | 2.86072388 |
| 126 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.86062330 |
| 127 | regulation of protein activation cascade (GO:2000257) | 2.85796089 |
| 128 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83429950 |
| 129 | macrophage activation (GO:0042116) | 2.83185897 |
| 130 | positive regulation of granulocyte differentiation (GO:0030854) | 2.82976105 |
| 131 | bile acid metabolic process (GO:0008206) | 2.82422461 |
| 132 | positive regulation of type 2 immune response (GO:0002830) | 2.82350226 |
| 133 | negative regulation of sterol transport (GO:0032372) | 2.81725537 |
| 134 | negative regulation of cholesterol transport (GO:0032375) | 2.81725537 |
| 135 | protein-lipid complex assembly (GO:0065005) | 2.81661276 |
| 136 | negative regulation of interleukin-6 production (GO:0032715) | 2.81502824 |
| 137 | cellular ketone body metabolic process (GO:0046950) | 2.81499151 |
| 138 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81324394 |
| 139 | positive regulation of B cell differentiation (GO:0045579) | 2.80892793 |
| 140 | regulation of regulatory T cell differentiation (GO:0045589) | 2.80632505 |
| 141 | biotin metabolic process (GO:0006768) | 2.80592548 |
| 142 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.80448080 |
| 143 | plasma lipoprotein particle clearance (GO:0034381) | 2.80446466 |
| 144 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.80174210 |
| 145 | response to host (GO:0075136) | 2.80174210 |
| 146 | response to host defenses (GO:0052200) | 2.80174210 |
| 147 | plasma lipoprotein particle remodeling (GO:0034369) | 2.79982748 |
| 148 | protein-lipid complex remodeling (GO:0034368) | 2.79982748 |
| 149 | macromolecular complex remodeling (GO:0034367) | 2.79982748 |
| 150 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.79322187 |
| 151 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.78060271 |
| 152 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.78060271 |
| 153 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.77824295 |
| 154 | branched-chain amino acid metabolic process (GO:0009081) | 2.77190051 |
| 155 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76679612 |
| 156 | acetyl-CoA metabolic process (GO:0006084) | 2.76277828 |
| 157 | complement activation, alternative pathway (GO:0006957) | 2.75947300 |
| 158 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75231684 |
| 159 | regulation of triglyceride metabolic process (GO:0090207) | 2.75215918 |
| 160 | regulation of leukocyte degranulation (GO:0043300) | 2.74778186 |
| 161 | regulation of fatty acid oxidation (GO:0046320) | 2.73376836 |
| 162 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.72614892 |
| 163 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.72552577 |
| 164 | leukocyte degranulation (GO:0043299) | 2.71271647 |
| 165 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.70578261 |
| 166 | detection of molecule of bacterial origin (GO:0032490) | 2.69717489 |
| 167 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.69474928 |
| 168 | indolalkylamine metabolic process (GO:0006586) | 2.68136871 |
| 169 | regulation of complement activation (GO:0030449) | 2.67617063 |
| 170 | positive regulation of tolerance induction (GO:0002645) | 2.67005719 |
| 171 | branched-chain amino acid catabolic process (GO:0009083) | 2.65766715 |
| 172 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.65625413 |
| 173 | mast cell activation (GO:0045576) | 2.65330226 |
| 174 | oxaloacetate metabolic process (GO:0006107) | 2.65205426 |
| 175 | positive regulation of lipid catabolic process (GO:0050996) | 2.65141165 |
| 176 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.63245178 |
| 177 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.62674208 |
| 178 | cholesterol efflux (GO:0033344) | 2.61651792 |
| 179 | alpha-amino acid catabolic process (GO:1901606) | 2.61564925 |
| 180 | aromatic amino acid family metabolic process (GO:0009072) | 2.61558881 |
| 181 | complement activation, classical pathway (GO:0006958) | 2.61557600 |
| 182 | organic acid catabolic process (GO:0016054) | 2.60323594 |
| 183 | carboxylic acid catabolic process (GO:0046395) | 2.60323594 |
| 184 | negative regulation of fibrinolysis (GO:0051918) | 2.59440696 |
| 185 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.59288819 |
| 186 | carnitine transmembrane transport (GO:1902603) | 2.58564401 |
| 187 | coenzyme catabolic process (GO:0009109) | 2.56147128 |
| 188 | tyrosine metabolic process (GO:0006570) | 2.53970429 |
| 189 | plasma lipoprotein particle organization (GO:0071827) | 2.53761543 |
| 190 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.53214416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.13357784 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.42117026 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.38688077 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.14336289 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.07108541 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.36470709 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.14925207 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.06538422 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.04445237 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.54521289 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.42696538 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.33628558 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.33566157 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.33162660 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25379912 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.21777250 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16329455 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.16260211 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15370830 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.06583679 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.02384206 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01350705 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94294785 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.90802154 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.90373166 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87565362 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83247433 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79857507 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79792091 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79657463 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76325847 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71240763 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.66646526 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66195060 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65934075 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65369045 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65110413 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60969627 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.60952959 |
| 40 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58735045 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.58216195 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56693149 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54902719 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54646347 |
| 45 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54000597 |
| 46 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48836242 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48488855 |
| 48 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47719046 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46791692 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43967128 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41353209 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41035736 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40742786 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40404105 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.38886273 |
| 56 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38286276 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37787398 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.37548554 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36830793 |
| 60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35785438 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.35736197 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35522402 |
| 63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34982804 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34515018 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33855554 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32117023 |
| 67 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.31570826 |
| 68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30909400 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30869697 |
| 70 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28099176 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26667904 |
| 72 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26460012 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21792971 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.21775122 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21217536 |
| 76 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18715778 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.17517271 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16298129 |
| 79 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15587566 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15505745 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15036693 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13850071 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13618560 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 1.12750951 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11286291 |
| 86 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.10623242 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10581544 |
| 88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10436912 |
| 89 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10274211 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09793122 |
| 91 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.09429405 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08791115 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08347135 |
| 94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08315206 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07484108 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06807874 |
| 97 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.06295364 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06146282 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.05533937 |
| 100 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05312715 |
| 101 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04534907 |
| 102 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04425211 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03844418 |
| 104 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03728186 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02997706 |
| 106 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02831094 |
| 107 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02025136 |
| 108 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01801312 |
| 109 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01700232 |
| 110 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00458523 |
| 111 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00438534 |
| 112 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00247743 |
| 113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99865193 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99858412 |
| 115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99695747 |
| 116 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.99682452 |
| 117 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99619991 |
| 118 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97988817 |
| 119 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97884422 |
| 120 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97667419 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97002619 |
| 122 | P300_27268052_Chip-Seq_Bcells_Human | 0.96341484 |
| 123 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95313937 |
| 124 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94902871 |
| 125 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94391577 |
| 126 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94203418 |
| 127 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.94120667 |
| 128 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93244998 |
| 129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92549769 |
| 130 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92247146 |
| 131 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.91826918 |
| 132 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.91826918 |
| 133 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90253402 |
| 134 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.89642666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.65995733 |
| 2 | MP0005365_abnormal_bile_salt | 3.97400786 |
| 3 | MP0005360_urolithiasis | 3.91658411 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.32427284 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.80691468 |
| 6 | MP0009840_abnormal_foam_cell | 2.63227602 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.46769601 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.43268288 |
| 9 | MP0003252_abnormal_bile_duct | 2.36257327 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.34670726 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.23118308 |
| 12 | MP0003195_calcinosis | 2.20134319 |
| 13 | MP0000685_abnormal_immune_system | 2.14143906 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.03569192 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.00130917 |
| 16 | MP0005083_abnormal_biliary_tract | 1.98453764 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 1.98223352 |
| 18 | MP0001533_abnormal_skeleton_physiology | 1.94290023 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.88507877 |
| 20 | MP0003436_decreased_susceptibility_to | 1.88314143 |
| 21 | MP0008260_abnormal_autophagy | 1.87173973 |
| 22 | MP0004510_myositis | 1.81026189 |
| 23 | MP0001790_abnormal_immune_system | 1.78349585 |
| 24 | MP0005387_immune_system_phenotype | 1.78349585 |
| 25 | MP0000609_abnormal_liver_physiology | 1.77921577 |
| 26 | MP0003646_muscle_fatigue | 1.74295239 |
| 27 | MP0004130_abnormal_muscle_cell | 1.73853106 |
| 28 | MP0001800_abnormal_humoral_immune | 1.73841959 |
| 29 | MP0005670_abnormal_white_adipose | 1.72850897 |
| 30 | MP0005671_abnormal_response_to | 1.69532269 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.66131033 |
| 32 | MP0003724_increased_susceptibility_to | 1.59169835 |
| 33 | MP0005332_abnormal_amino_acid | 1.58897502 |
| 34 | MP0001873_stomach_inflammation | 1.58732804 |
| 35 | MP0001853_heart_inflammation | 1.56339831 |
| 36 | MP0009785_altered_susceptibility_to | 1.56160149 |
| 37 | * MP0002118_abnormal_lipid_homeostasis | 1.54248097 |
| 38 | MP0005025_abnormal_response_to | 1.51778369 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.50146088 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.47144728 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.43170001 |
| 42 | MP0004381_abnormal_hair_follicle | 1.42279387 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.42228564 |
| 44 | MP0005310_abnormal_salivary_gland | 1.40967069 |
| 45 | * MP0005319_abnormal_enzyme/_coenzyme | 1.40539044 |
| 46 | MP0002723_abnormal_immune_serum | 1.40204726 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.38957988 |
| 48 | MP0002419_abnormal_innate_immunity | 1.38763252 |
| 49 | MP0008469_abnormal_protein_level | 1.36218666 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.34299514 |
| 51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32636725 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.32510055 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.29109772 |
| 54 | MP0009764_decreased_sensitivity_to | 1.26545547 |
| 55 | MP0001819_abnormal_immune_cell | 1.25971966 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.25932401 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.25320309 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.25023430 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.22540748 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.22241229 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.21931047 |
| 62 | MP0005330_cardiomyopathy | 1.20653858 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.19475651 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.19314675 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.19214979 |
| 66 | MP0005220_abnormal_exocrine_pancreas | 1.18388748 |
| 67 | MP0004084_abnormal_cardiac_muscle | 1.17191999 |
| 68 | MP0004036_abnormal_muscle_relaxation | 1.13394373 |
| 69 | MP0000598_abnormal_liver_morphology | 1.11276446 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.10398979 |
| 71 | MP0002398_abnormal_bone_marrow | 1.08828323 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.07816448 |
| 73 | MP0000716_abnormal_immune_system | 1.07664148 |
| 74 | MP0001764_abnormal_homeostasis | 1.06391958 |
| 75 | MP0003866_abnormal_defecation | 1.06130868 |
| 76 | MP0009278_abnormal_bone_marrow | 1.05152805 |
| 77 | MP0009763_increased_sensitivity_to | 1.04398221 |
| 78 | MP0001663_abnormal_digestive_system | 1.04007472 |
| 79 | MP0008004_abnormal_stomach_pH | 1.03035258 |
| 80 | MP0001851_eye_inflammation | 1.02960081 |
| 81 | MP0004019_abnormal_vitamin_homeostasis | 1.02346351 |
| 82 | MP0000858_altered_metastatic_potential | 1.01641289 |
| 83 | MP0003868_abnormal_feces_composition | 1.00820855 |
| 84 | MP0005166_decreased_susceptibility_to | 0.99780280 |
| 85 | MP0003075_altered_response_to | 0.99585187 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 0.98840618 |
| 87 | MP0002254_reproductive_system_inflammat | 0.98829681 |
| 88 | MP0002405_respiratory_system_inflammati | 0.96839309 |
| 89 | MP0002429_abnormal_blood_cell | 0.95867769 |
| 90 | MP0005390_skeleton_phenotype | 0.93655502 |
| 91 | MP0003183_abnormal_peptide_metabolism | 0.93410330 |
| 92 | MP0008775_abnormal_heart_ventricle | 0.93391060 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.93132532 |
| 94 | MP0009642_abnormal_blood_homeostasis | 0.92841975 |
| 95 | MP0004947_skin_inflammation | 0.92760532 |
| 96 | MP0002722_abnormal_immune_system | 0.91598157 |
| 97 | MP0010630_abnormal_cardiac_muscle | 0.91054953 |
| 98 | MP0003300_gastrointestinal_ulcer | 0.90526372 |
| 99 | * MP0000749_muscle_degeneration | 0.90502776 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 0.88983315 |
| 101 | MP0001958_emphysema | 0.88371160 |
| 102 | MP0005451_abnormal_body_composition | 0.88211650 |
| 103 | MP0005397_hematopoietic_system_phenotyp | 0.87343549 |
| 104 | MP0001545_abnormal_hematopoietic_system | 0.87343549 |
| 105 | MP0000343_altered_response_to | 0.86834431 |
| 106 | MP0002971_abnormal_brown_adipose | 0.86438971 |
| 107 | MP0002928_abnormal_bile_duct | 0.85318273 |
| 108 | MP0005334_abnormal_fat_pad | 0.84370497 |
| 109 | MP0000604_amyloidosis | 0.83985045 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.83950674 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.83290351 |
| 112 | MP0002933_joint_inflammation | 0.82946576 |
| 113 | MP0001986_abnormal_taste_sensitivity | 0.82563899 |
| 114 | MP0003828_pulmonary_edema | 0.82421643 |
| 115 | MP0003303_peritoneal_inflammation | 0.82186552 |
| 116 | MP0002132_abnormal_respiratory_system | 0.81670275 |
| 117 | MP0004883_abnormal_blood_vessel | 0.81491347 |
| 118 | MP0003690_abnormal_glial_cell | 0.80670825 |
| 119 | MP0006082_CNS_inflammation | 0.79499975 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.76648590 |
| 121 | MP0009697_abnormal_copulation | 0.76646817 |
| 122 | MP0005164_abnormal_response_to | 0.75782809 |
| 123 | MP0001879_abnormal_lymphatic_vessel | 0.75600880 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.75057988 |
| 125 | MP0000249_abnormal_blood_vessel | 0.74966227 |
| 126 | MP0003186_abnormal_redox_activity | 0.74820222 |
| 127 | MP0004808_abnormal_hematopoietic_stem | 0.74522608 |
| 128 | MP0005535_abnormal_body_temperature | 0.73917363 |
| 129 | MP0000490_abnormal_crypts_of | 0.71503708 |
| 130 | MP0003279_aneurysm | 0.69842876 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.68395152 |
| 132 | MP0003045_fibrosis | 0.67745617 |
| 133 | MP0003448_altered_tumor_morphology | 0.67621512 |
| 134 | MP0005375_adipose_tissue_phenotype | 0.67167294 |
| 135 | MP0003795_abnormal_bone_structure | 0.65582740 |
| 136 | MP0005381_digestive/alimentary_phenotyp | 0.64826956 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.59584925 |
| 138 | MP0004185_abnormal_adipocyte_glucose | 0.56957347 |
| 139 | MP0008874_decreased_physiological_sensi | 0.54945037 |
| 140 | MP0009115_abnormal_fat_cell | 0.50634445 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.49835964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 4.61225256 |
| 2 | Hypoglycemic coma (HP:0001325) | 4.50141623 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.46723986 |
| 4 | Stomatitis (HP:0010280) | 4.18334546 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 3.95854347 |
| 6 | Orchitis (HP:0100796) | 3.95844700 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.91597931 |
| 8 | Meningitis (HP:0001287) | 3.90459428 |
| 9 | Obstructive lung disease (HP:0006536) | 3.89545879 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.89545879 |
| 11 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.86056058 |
| 12 | Optic neuritis (HP:0100653) | 3.70443791 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.70443791 |
| 14 | Ketosis (HP:0001946) | 3.55397510 |
| 15 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.51444067 |
| 16 | Xanthomatosis (HP:0000991) | 3.49591486 |
| 17 | Vasculitis (HP:0002633) | 3.48358322 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.45209233 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.45209233 |
| 20 | Recurrent skin infections (HP:0001581) | 3.44610501 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.41543379 |
| 22 | Intrahepatic cholestasis (HP:0001406) | 3.39511466 |
| 23 | Ketoacidosis (HP:0001993) | 3.37291926 |
| 24 | Generalized aminoaciduria (HP:0002909) | 3.36840422 |
| 25 | Increased IgE level (HP:0003212) | 3.34925162 |
| 26 | Hyperammonemia (HP:0001987) | 3.29317514 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.25112580 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.25112580 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.25112580 |
| 30 | Hyperglycinuria (HP:0003108) | 3.17547449 |
| 31 | Panhypogammaglobulinemia (HP:0003139) | 3.16786836 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 3.15675159 |
| 33 | Prolonged partial thromboplastin time (HP:0003645) | 3.06612626 |
| 34 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.06474366 |
| 35 | Dicarboxylic aciduria (HP:0003215) | 3.06474366 |
| 36 | Deep venous thrombosis (HP:0002625) | 3.06084347 |
| 37 | Recurrent viral infections (HP:0004429) | 3.05938705 |
| 38 | Cellulitis (HP:0100658) | 3.04375631 |
| 39 | Encephalitis (HP:0002383) | 3.03307018 |
| 40 | Pulmonary infiltrates (HP:0002113) | 3.02198087 |
| 41 | Myoglobinuria (HP:0002913) | 3.01485700 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.94501304 |
| 43 | Gingivitis (HP:0000230) | 2.94229352 |
| 44 | Conjugated hyperbilirubinemia (HP:0002908) | 2.93351387 |
| 45 | Hemoptysis (HP:0002105) | 2.91724468 |
| 46 | Hypobetalipoproteinemia (HP:0003563) | 2.91234918 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.90339365 |
| 48 | Late onset (HP:0003584) | 2.88983383 |
| 49 | Hypoglycemic seizures (HP:0002173) | 2.79184015 |
| 50 | Increased IgM level (HP:0003496) | 2.78373870 |
| 51 | Joint hemorrhage (HP:0005261) | 2.75398010 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.75309348 |
| 53 | Chest pain (HP:0100749) | 2.73206388 |
| 54 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.72198210 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.72133072 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.72133072 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.72133072 |
| 58 | Vacuolated lymphocytes (HP:0001922) | 2.71376859 |
| 59 | Eczematoid dermatitis (HP:0000976) | 2.63384911 |
| 60 | Urticaria (HP:0001025) | 2.58123710 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.54027209 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53432620 |
| 63 | Complement deficiency (HP:0004431) | 2.52969233 |
| 64 | Gastrointestinal stroma tumor (HP:0100723) | 2.52797463 |
| 65 | Metabolic acidosis (HP:0001942) | 2.52734781 |
| 66 | Asymmetric septal hypertrophy (HP:0001670) | 2.52733577 |
| 67 | T lymphocytopenia (HP:0005403) | 2.52326265 |
| 68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.51975961 |
| 69 | Osteomyelitis (HP:0002754) | 2.50042611 |
| 70 | Malnutrition (HP:0004395) | 2.49856843 |
| 71 | Abnormality of the common coagulation pathway (HP:0010990) | 2.49625703 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.47806208 |
| 73 | Amyloidosis (HP:0011034) | 2.47792158 |
| 74 | Abnormality of T cell number (HP:0011839) | 2.46682688 |
| 75 | Granulocytopenia (HP:0001913) | 2.46421023 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 2.46329737 |
| 77 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.46329737 |
| 78 | Renal cortical cysts (HP:0000803) | 2.45209479 |
| 79 | Colitis (HP:0002583) | 2.44726720 |
| 80 | Lymphopenia (HP:0001888) | 2.44466423 |
| 81 | Systemic lupus erythematosus (HP:0002725) | 2.43490869 |
| 82 | Leukocytosis (HP:0001974) | 2.43478572 |
| 83 | Loss of speech (HP:0002371) | 2.43223293 |
| 84 | Abnormality of T cells (HP:0002843) | 2.42561571 |
| 85 | Epidermoid cyst (HP:0200040) | 2.41557857 |
| 86 | Restrictive lung disease (HP:0002091) | 2.40994573 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.40466336 |
| 88 | Mucopolysacchariduria (HP:0008155) | 2.40466336 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.39451559 |
| 90 | IgM deficiency (HP:0002850) | 2.38713537 |
| 91 | Abnormality of the fingertips (HP:0001211) | 2.35995086 |
| 92 | Severe visual impairment (HP:0001141) | 2.35903825 |
| 93 | Fat malabsorption (HP:0002630) | 2.33122853 |
| 94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.32770097 |
| 95 | Episodic fever (HP:0001954) | 2.32748533 |
| 96 | Abnormality of the pleura (HP:0002103) | 2.32483351 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.31508296 |
| 98 | Nausea (HP:0002018) | 2.29946606 |
| 99 | Hypolipoproteinemia (HP:0010981) | 2.29792251 |
| 100 | Keratoconjunctivitis (HP:0001096) | 2.28662346 |
| 101 | Purpura (HP:0000979) | 2.28462830 |
| 102 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25049821 |
| 103 | Hyperglycinemia (HP:0002154) | 2.23862044 |
| 104 | Emphysema (HP:0002097) | 2.23425870 |
| 105 | Hypercholesterolemia (HP:0003124) | 2.23194637 |
| 106 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.23111739 |
| 107 | Hepatosplenomegaly (HP:0001433) | 2.23089519 |
| 108 | Recurrent bacterial skin infections (HP:0005406) | 2.22902880 |
| 109 | Recurrent abscess formation (HP:0002722) | 2.20816460 |
| 110 | Mitral stenosis (HP:0001718) | 2.18428588 |
| 111 | Pulmonary embolism (HP:0002204) | 2.16577920 |
| 112 | Acne (HP:0001061) | 2.16432467 |
| 113 | Chronic diarrhea (HP:0002028) | 2.15875637 |
| 114 | Hypoalphalipoproteinemia (HP:0003233) | 2.14978462 |
| 115 | Abnormality of the intrinsic pathway (HP:0010989) | 2.14208718 |
| 116 | Limb hypertonia (HP:0002509) | 2.13431974 |
| 117 | Increased muscle lipid content (HP:0009058) | 2.12689727 |
| 118 | Rhabdomyolysis (HP:0003201) | 2.11755950 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 2.11584888 |
| 120 | Pancreatitis (HP:0001733) | 2.11165881 |
| 121 | Exercise-induced myalgia (HP:0003738) | 2.10292924 |
| 122 | Recurrent pneumonia (HP:0006532) | 2.10064118 |
| 123 | Hydroxyprolinuria (HP:0003080) | 2.09314858 |
| 124 | Abnormality of proline metabolism (HP:0010907) | 2.09314858 |
| 125 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.08225849 |
| 126 | Petechiae (HP:0000967) | 2.08061430 |
| 127 | Ventricular tachycardia (HP:0004756) | 2.07859468 |
| 128 | Hepatic necrosis (HP:0002605) | 2.05819853 |
| 129 | Inflammation of the large intestine (HP:0002037) | 2.05667315 |
| 130 | Ragged-red muscle fibers (HP:0003200) | 2.05495069 |
| 131 | Recurrent bronchitis (HP:0002837) | 2.04663939 |
| 132 | Symptomatic seizures (HP:0011145) | 2.04210188 |
| 133 | Increased serum ferritin (HP:0003281) | 2.03298064 |
| 134 | Chronic otitis media (HP:0000389) | 2.03026121 |
| 135 | Skin nodule (HP:0200036) | 2.02334593 |
| 136 | Seborrheic dermatitis (HP:0001051) | 2.01940054 |
| 137 | Papilloma (HP:0012740) | 2.01533161 |
| 138 | Verrucae (HP:0200043) | 2.01533161 |
| 139 | Impaired platelet aggregation (HP:0003540) | 2.00532576 |
| 140 | Abnormal platelet function (HP:0011869) | 2.00532576 |
| 141 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.00301541 |
| 142 | J-shaped sella turcica (HP:0002680) | 1.99464157 |
| 143 | Arthralgia (HP:0002829) | 1.99245257 |
| 144 | Nasal polyposis (HP:0100582) | 1.98404883 |
| 145 | Elevated hepatic transaminases (HP:0002910) | 1.97795545 |
| 146 | Gastrointestinal inflammation (HP:0004386) | 1.97747507 |
| 147 | Palpitations (HP:0001962) | 1.97433974 |
| 148 | Sepsis (HP:0100806) | 1.97164319 |
| 149 | Hypochromic anemia (HP:0001931) | 1.95402948 |
| 150 | Interstitial pulmonary disease (HP:0006530) | 1.95205906 |
| 151 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95202540 |
| 152 | Myocardial infarction (HP:0001658) | 1.95128537 |
| 153 | Joint swelling (HP:0001386) | 1.94841784 |
| 154 | Gingival bleeding (HP:0000225) | 1.92784267 |
| 155 | Neoplasm of head and neck (HP:0012288) | 1.92468547 |
| 156 | Esophageal neoplasm (HP:0100751) | 1.92468547 |
| 157 | Abnormality of the nasal mucosa (HP:0000433) | 1.92009327 |
| 158 | Lipoatrophy (HP:0100578) | 1.91896876 |
| 159 | Recurrent lower respiratory tract infections (HP:0002783) | 1.91805076 |
| 160 | Polygenic inheritance (HP:0010982) | 1.90164861 |
| 161 | Growth hormone excess (HP:0000845) | 1.87114446 |
| 162 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.85785907 |
| 163 | * Dilated cardiomyopathy (HP:0001644) | 1.85504021 |
| 164 | Proximal tubulopathy (HP:0000114) | 1.85123246 |
| 165 | Autoimmune thrombocytopenia (HP:0001973) | 1.85019824 |
| 166 | Abnormality of nucleobase metabolism (HP:0010932) | 1.83593065 |
| 167 | Pustule (HP:0200039) | 1.83252975 |
| 168 | Gastrointestinal infarctions (HP:0005244) | 1.82572288 |
| 169 | Abnormality of purine metabolism (HP:0004352) | 1.82496645 |
| 170 | Myositis (HP:0100614) | 1.82314334 |
| 171 | Epistaxis (HP:0000421) | 1.81918117 |
| 172 | Recurrent fungal infections (HP:0002841) | 1.80904654 |
| 173 | Agammaglobulinemia (HP:0004432) | 1.80227966 |
| 174 | Recurrent sinusitis (HP:0011108) | 1.79690398 |
| 175 | Abnormality of methionine metabolism (HP:0010901) | 1.79364266 |
| 176 | Abnormality of iron homeostasis (HP:0011031) | 1.79109659 |
| 177 | Abnormality of complement system (HP:0005339) | 1.78907319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.58283594 |
| 2 | MAP4K1 | 3.41018328 |
| 3 | ERN1 | 3.36926730 |
| 4 | RIPK4 | 3.25672352 |
| 5 | IRAK3 | 2.68779404 |
| 6 | MAPK15 | 2.52527611 |
| 7 | TRIB3 | 2.49643644 |
| 8 | FGFR4 | 2.45222723 |
| 9 | TBK1 | 2.37577494 |
| 10 | MAP3K10 | 2.36754843 |
| 11 | TNK2 | 2.33357757 |
| 12 | FES | 2.14253438 |
| 13 | TYK2 | 2.10883606 |
| 14 | MAP2K3 | 1.96340210 |
| 15 | IKBKE | 1.87940991 |
| 16 | KIT | 1.87938930 |
| 17 | ZAP70 | 1.87390644 |
| 18 | INSRR | 1.86867879 |
| 19 | MAP3K14 | 1.83260566 |
| 20 | PIK3CG | 1.82473914 |
| 21 | SIK1 | 1.82115655 |
| 22 | MYLK | 1.78533915 |
| 23 | FLT3 | 1.73888778 |
| 24 | BTK | 1.71616089 |
| 25 | PKN2 | 1.66104584 |
| 26 | IRAK4 | 1.63546131 |
| 27 | TGFBR2 | 1.57466317 |
| 28 | PRKD2 | 1.55425286 |
| 29 | JAK3 | 1.53716876 |
| 30 | TXK | 1.50386460 |
| 31 | MAPKAPK3 | 1.49375122 |
| 32 | TEC | 1.41896414 |
| 33 | BLK | 1.38809998 |
| 34 | JAK1 | 1.38382585 |
| 35 | TTN | 1.35584620 |
| 36 | KDR | 1.35406865 |
| 37 | MARK2 | 1.31652391 |
| 38 | IKBKB | 1.31636926 |
| 39 | TAOK3 | 1.26823147 |
| 40 | CDC42BPA | 1.26030778 |
| 41 | EPHA3 | 1.23872283 |
| 42 | ITK | 1.17466520 |
| 43 | CHUK | 1.16316005 |
| 44 | TIE1 | 1.15254443 |
| 45 | SYK | 1.15126405 |
| 46 | FGR | 1.09837558 |
| 47 | RPS6KA4 | 1.07335986 |
| 48 | TAOK2 | 1.07245372 |
| 49 | MARK3 | 1.04429212 |
| 50 | TAOK1 | 1.03868514 |
| 51 | OBSCN | 1.00833890 |
| 52 | PTK6 | 0.98194332 |
| 53 | CSF1R | 0.98079056 |
| 54 | MAP3K11 | 0.96832368 |
| 55 | MAP3K7 | 0.93949113 |
| 56 | MAP3K6 | 0.90687092 |
| 57 | PRKAA2 | 0.88000889 |
| 58 | GRK6 | 0.87635231 |
| 59 | RIPK1 | 0.86561943 |
| 60 | DYRK1B | 0.84715480 |
| 61 | NLK | 0.83047869 |
| 62 | STK16 | 0.80111774 |
| 63 | PDK1 | 0.79603271 |
| 64 | HIPK2 | 0.79395443 |
| 65 | CAMK1D | 0.78875734 |
| 66 | NEK9 | 0.77502853 |
| 67 | CSK | 0.77159090 |
| 68 | PRKCQ | 0.76963614 |
| 69 | LCK | 0.76078145 |
| 70 | IRAK1 | 0.76052248 |
| 71 | EPHB1 | 0.75800432 |
| 72 | PINK1 | 0.74700744 |
| 73 | MAPK7 | 0.74329869 |
| 74 | JAK2 | 0.74060871 |
| 75 | GRK7 | 0.73600041 |
| 76 | SIK3 | 0.71876952 |
| 77 | PRKG2 | 0.71748524 |
| 78 | NME2 | 0.71492426 |
| 79 | MAP2K6 | 0.70739228 |
| 80 | MAP3K13 | 0.69667466 |
| 81 | MAP3K3 | 0.68929928 |
| 82 | PDPK1 | 0.68360170 |
| 83 | STK38 | 0.67411004 |
| 84 | FYN | 0.66089498 |
| 85 | LYN | 0.65289687 |
| 86 | PHKG2 | 0.63203909 |
| 87 | PHKG1 | 0.63203909 |
| 88 | CAMKK1 | 0.62848380 |
| 89 | HCK | 0.62553093 |
| 90 | ZAK | 0.62330171 |
| 91 | MAPK11 | 0.61727349 |
| 92 | PIM1 | 0.60302124 |
| 93 | MUSK | 0.60246827 |
| 94 | CDK4 | 0.56370734 |
| 95 | MAPK12 | 0.55609934 |
| 96 | BMPR2 | 0.54947226 |
| 97 | RPS6KA6 | 0.54102619 |
| 98 | PRPF4B | 0.53146377 |
| 99 | FGFR3 | 0.53121390 |
| 100 | RPS6KA2 | 0.49656242 |
| 101 | CDK19 | 0.49451707 |
| 102 | DAPK2 | 0.48715812 |
| 103 | PRKD1 | 0.46541411 |
| 104 | PRKAA1 | 0.45118563 |
| 105 | CAMK4 | 0.44378505 |
| 106 | PTK2B | 0.44306244 |
| 107 | MAPK4 | 0.43577816 |
| 108 | MATK | 0.42544597 |
| 109 | MAP3K1 | 0.40991365 |
| 110 | STK10 | 0.40541879 |
| 111 | PRKCH | 0.40447707 |
| 112 | TGFBR1 | 0.39052156 |
| 113 | MAPK3 | 0.38597513 |
| 114 | SMG1 | 0.38589127 |
| 115 | LRRK2 | 0.38341123 |
| 116 | CDK9 | 0.38044170 |
| 117 | DYRK3 | 0.37981806 |
| 118 | NUAK1 | 0.37960852 |
| 119 | STK11 | 0.37124603 |
| 120 | RPS6KL1 | 0.36275764 |
| 121 | RPS6KC1 | 0.36275764 |
| 122 | TESK2 | 0.36118869 |
| 123 | GRK1 | 0.35800071 |
| 124 | LMTK2 | 0.35518258 |
| 125 | MAP3K12 | 0.34164753 |
| 126 | MAP2K2 | 0.33766679 |
| 127 | CAMK1 | 0.33467901 |
| 128 | PIM2 | 0.33053433 |
| 129 | RPS6KA5 | 0.32290897 |
| 130 | SIK2 | 0.31784875 |
| 131 | MAPKAPK2 | 0.31627309 |
| 132 | CAMK1G | 0.31519534 |
| 133 | BMX | 0.29252121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.38349675 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.21290206 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.92226493 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.88770847 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.80295884 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.75501929 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54562925 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.39608529 |
| 9 | Peroxisome_Homo sapiens_hsa04146 | 2.22922508 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.21068331 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19000578 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.18954858 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.16825897 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.15644832 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.14418822 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00937246 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.98055273 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.97524555 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.93837719 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.93259739 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.92885001 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92185364 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86659159 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.82328819 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.79542117 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.72974037 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71407203 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.65010606 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.63980617 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.63659950 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61903347 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.59649392 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55800099 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.54860211 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50132569 |
| 36 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.49556874 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46900175 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.46017080 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.44071454 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43079655 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42790540 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41723802 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41705957 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.41551275 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41423181 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40934245 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33966401 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33167215 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32242176 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31265919 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31127514 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29013400 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 1.26842502 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 1.25529232 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23646342 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23264188 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19903270 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15155397 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11846616 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09010561 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08003788 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02665597 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02341235 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01855238 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 1.01230477 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 1.00221641 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98759651 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.97868168 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95535565 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.95323516 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94629664 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.93988727 |
| 73 | Hepatitis B_Homo sapiens_hsa05161 | 0.93244562 |
| 74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92366995 |
| 75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.90821078 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89000259 |
| 77 | Salmonella infection_Homo sapiens_hsa05132 | 0.87909426 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87034169 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.86290316 |
| 80 | Shigellosis_Homo sapiens_hsa05131 | 0.85905993 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85682667 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84869562 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84681404 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83572292 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.83541379 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83356732 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83296481 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79596668 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77704948 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77380462 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76741648 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75527417 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73071811 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72371113 |
| 95 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72178270 |
| 96 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.71979664 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.71155587 |
| 98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70260416 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.70207168 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69930301 |
| 101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67064719 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66121177 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65315671 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62248556 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61649960 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61532846 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.61461081 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61223333 |
| 109 | Asthma_Homo sapiens_hsa05310 | 0.60739545 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60505343 |
| 111 | Protein export_Homo sapiens_hsa03060 | 0.59185584 |
| 112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59098790 |
| 113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59045060 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58371552 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57966281 |
| 116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57821029 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56947866 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56588897 |
| 119 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55062734 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54525284 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52766328 |
| 122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52127131 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51067570 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49715467 |
| 125 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49146474 |
| 126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48812800 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48149194 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47255658 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46974895 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.46548006 |
| 131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46394982 |
| 132 | Influenza A_Homo sapiens_hsa05164 | 0.46171562 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44666006 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43383483 |
| 135 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43322407 |
| 136 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43251020 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42801461 |
| 138 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42065874 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40336655 |
| 140 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.40116426 |
| 141 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.37957288 |
| 142 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35921338 |
| 143 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35406374 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35010174 |
| 145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34937678 |
| 146 | Apoptosis_Homo sapiens_hsa04210 | 0.34873677 |
| 147 | Lysosome_Homo sapiens_hsa04142 | 0.34608478 |
| 148 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34446433 |
| 149 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33601376 |
| 150 | Pertussis_Homo sapiens_hsa05133 | 0.32258730 |
| 151 | Hepatitis C_Homo sapiens_hsa05160 | 0.31338891 |
| 152 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.30103851 |
| 153 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29606796 |
| 154 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29580515 |
| 155 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28869612 |
| 156 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27764109 |
| 157 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27743615 |
| 158 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26581857 |
| 159 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25115618 |
| 160 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24288539 |
| 161 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22660252 |

